Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × UNKNOWN × nedaplatin × Clear all

Phase

Phase 2 3 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

OTHER 3 UNKNOWN 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

Paclitaxel 3 S 1 (combination) 2 Oxaliplatin 2 Irinotecan 2 Cisplatin 2 Capecitabine 2 titanium silicide 1 nedaplatin 1 anlotinib 1 Radiation 1 Pemetrexed 1 Lenalidomide 1 HMPL-013 1 Gemcitabine 1 Esophagectomy 1 Clinical Trials, Phase II as Topic 1 Clinical Trials, Phase I as Topic 1 Carboplatin 1 Bevacizumab 1 Bendamustine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02429622 2017-01-18

Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma

ChineseAMS

Phase 1/2 Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡